P112 The British Hair and Nail Society present a review of our national grand round of challenging nail conditions and the benefits to the wider British Association of Dermatologists membership

Sonia Sharma,Athina Fonia,Megan Mowbray,Anita Takwale,Leila Asfour,Dhruvkumar Laheru

DOI: https://doi.org/10.1093/bjd/ljae090.139

IF: 11.113

2024-06-28

British Journal of Dermatology

Abstract:Abstract The British Hair and Nail Society (BHNS) was formed in 2011. We currently have 133 members and invite them to submit challenging cases of nail disorders to our grand round (with relevant history, histopathology and photo- graphs) for review by our expert nail panel. This comprises consultants with nail expertise from around the UK, and together we aim to address the referrers’ queries relating to diagnosis, treatment or both. We appreciate the com- plexity of nail conditions and the limited number of special- ists around the country with an interest in nail conditions. Therefore, we have recently offered the opportunity for all British Association of Dermatologists (BAD) members to submit cases once a year. The aim of our review is to pres- ent the type of complex nail conditions and queries that have been referred to our dedicated national nail conditions grand round and to showcase some of the most educational cases. The nail conditions grand round began in 2018, and since then a total of 21 nail cases (three children and 18 adults) have been submitted from various regions. The main aims of referral included diagnostic expertise (n = 7), aid with treatment plans (n = 3) or both (n = 9). Two cases were referred for help with the need for diagnostic nail biopsy. The median age of patients was 45 years (range 12−77). The cases involved 14 female and 7 male patients. The regions of referral include Gloucestershire, Reading, Cambridge and Scotland. The diagnosis was altered in nine cases (43%). The most common nail condition was psoriasis with nail involvement (n = 4), with the possibility of concurrent condi- tions such as chronic paronychia and subungual keratosis. In one of these cases where the extent of psoriatic nail disease was causing huge psychological burden for the patient, but their Psoriasis Area and Severity Index score was < 10, we supported the application of an individual funding request for biologic therapy. Examples of some of our rare diagnoses include nailbed seborrhoeic keratosis presenting as leucox- anthonychia, and a nailbed myxoid cyst following osteoar- thritic degeneration in distal interphalangeal joints. We hope our presentation showcases to the wider BAD membership the value of our national nail conditions grand round in supporting complex diagnostic and therapeutic decisions, as well as offering support for clinicians in the form of independent funding request submissions or trialling novel therapies, which may have limited evidence. We welcome any future submissions.

dermatology